vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Orion Properties Inc. (ONL). Click either name above to swap in a different company.
Orion Properties Inc. is the larger business by last-quarter revenue ($36.3M vs $19.2M, roughly 1.9× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -37.4%, a 30.6% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -4.6%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -4.9%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
APYX vs ONL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $36.3M |
| Net Profit | $-1.3M | $-13.6M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | -9.3% |
| Net Margin | -6.8% | -37.4% |
| Revenue YoY | 34.7% | -4.6% |
| Net Profit YoY | 71.9% | -45.0% |
| EPS (diluted) | — | $-0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $36.3M | ||
| Q4 25 | $19.2M | $35.2M | ||
| Q3 25 | $12.9M | $37.1M | ||
| Q2 25 | $11.4M | $37.3M | ||
| Q1 25 | $9.4M | $38.0M | ||
| Q4 24 | $14.2M | $38.4M | ||
| Q3 24 | $11.5M | $39.2M | ||
| Q2 24 | $12.1M | $40.1M |
| Q1 26 | — | $-13.6M | ||
| Q4 25 | $-1.3M | $-35.8M | ||
| Q3 25 | $-2.0M | $-69.0M | ||
| Q2 25 | $-3.8M | $-25.1M | ||
| Q1 25 | $-4.2M | $-9.4M | ||
| Q4 24 | $-4.6M | $-32.8M | ||
| Q3 24 | $-4.7M | $-10.2M | ||
| Q2 24 | $-6.6M | $-33.8M |
| Q1 26 | — | — | ||
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — |
| Q1 26 | — | -9.3% | ||
| Q4 25 | 0.1% | -101.5% | ||
| Q3 25 | -6.5% | -185.8% | ||
| Q2 25 | -22.6% | -67.1% | ||
| Q1 25 | -32.4% | -24.4% | ||
| Q4 24 | -21.4% | -85.4% | ||
| Q3 24 | -31.6% | -25.9% | ||
| Q2 24 | -45.7% | -84.1% |
| Q1 26 | — | -37.4% | ||
| Q4 25 | -6.8% | -101.7% | ||
| Q3 25 | -15.4% | -186.0% | ||
| Q2 25 | -33.2% | -67.3% | ||
| Q1 25 | -44.0% | -24.6% | ||
| Q4 24 | -32.5% | -85.4% | ||
| Q3 24 | -40.9% | -26.1% | ||
| Q2 24 | -54.0% | -84.2% |
| Q1 26 | — | $-0.24 | ||
| Q4 25 | — | $-0.63 | ||
| Q3 25 | — | $-1.23 | ||
| Q2 25 | — | $-0.45 | ||
| Q1 25 | — | $-0.17 | ||
| Q4 24 | — | $-0.59 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | $-0.19 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $10.3M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $608.5M |
| Total Assets | $66.8M | $1.2B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $10.3M | ||
| Q4 25 | $31.7M | $22.4M | ||
| Q3 25 | $25.1M | $32.6M | ||
| Q2 25 | $29.3M | $17.4M | ||
| Q1 25 | $31.0M | $9.4M | ||
| Q4 24 | $31.7M | $15.6M | ||
| Q3 24 | $28.0M | $16.6M | ||
| Q2 24 | $32.7M | $24.2M |
| Q1 26 | — | — | ||
| Q4 25 | $37.5M | $465.0M | ||
| Q3 25 | $37.5M | $483.0M | ||
| Q2 25 | $37.5M | $483.0M | ||
| Q1 25 | $37.5M | $505.0M | ||
| Q4 24 | $37.5M | $492.0M | ||
| Q3 24 | $37.5M | $485.0M | ||
| Q2 24 | — | $462.0M |
| Q1 26 | — | $608.5M | ||
| Q4 25 | $14.5M | $623.2M | ||
| Q3 25 | $5.8M | $658.8M | ||
| Q2 25 | $7.3M | $728.0M | ||
| Q1 25 | $10.5M | $753.5M | ||
| Q4 24 | $14.2M | $763.9M | ||
| Q3 24 | $11.0M | $800.9M | ||
| Q2 24 | $14.7M | $816.1M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $66.8M | $1.2B | ||
| Q3 25 | $57.4M | $1.2B | ||
| Q2 25 | $58.2M | $1.3B | ||
| Q1 25 | $60.2M | $1.3B | ||
| Q4 24 | $64.8M | $1.3B | ||
| Q3 24 | $60.7M | $1.4B | ||
| Q2 24 | $65.4M | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | 2.58× | 0.75× | ||
| Q3 25 | 6.41× | 0.73× | ||
| Q2 25 | 5.17× | 0.66× | ||
| Q1 25 | 3.57× | 0.67× | ||
| Q4 24 | 2.64× | 0.64× | ||
| Q3 24 | 3.40× | 0.61× | ||
| Q2 24 | — | 0.57× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | — |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | 51.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | $23.6M | ||
| Q3 25 | $-3.5M | $5.7M | ||
| Q2 25 | $-1.2M | $11.6M | ||
| Q1 25 | $-702.0K | $-2.2M | ||
| Q4 24 | $-2.9M | $54.3M | ||
| Q3 24 | $-4.4M | $13.8M | ||
| Q2 24 | $-4.3M | $17.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — |
| Q1 26 | — | 51.4% | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
ONL
| Rental | $36.1M | 100% |
| Fee income from unconsolidated joint venture | $137.0K | 0% |
